Does SUNITINIB Cause Malignant neoplasm progression? 242 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 242 reports of Malignant neoplasm progression have been filed in association with SUNITINIB. This represents 13.6% of all adverse event reports for SUNITINIB.
242
Reports of Malignant neoplasm progression with SUNITINIB
13.6%
of all SUNITINIB reports
80
Deaths
32
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SUNITINIB?
Of the 242 reports, 80 (33.1%) resulted in death, 32 (13.2%) required hospitalization, and 7 (2.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUNITINIB. However, 242 reports have been filed with the FAERS database.
What Other Side Effects Does SUNITINIB Cause?
Disease progression (280)
Drug ineffective (243)
Fatigue (132)
Diarrhoea (129)
Osteonecrosis of jaw (115)
Hypertension (99)
Off label use (99)
Thrombocytopenia (96)
Death (85)
Palmar-plantar erythrodysaesthesia syndrome (84)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SUNITINIB Alternatives Have Lower Malignant neoplasm progression Risk?
SUNITINIB vs SUNITINIB MALATE
SUNITINIB vs SUTENT
SUNITINIB vs SUTIMLIMAB-JOME
SUNITINIB vs SUVOREXANT
SUNITINIB vs SUZETRIGINE